The Inflation Reduction Act of 2022 will raise taxes, increase spending, and prolong both inflation and the recession.
Senators Need to Check Their Conscience Before Voting for Price Controls
Senators must understand that price controls will harm patients and reduce the development of future cures.
Subcommittee Hearing Tries to Shed Light on COVID-19 Relief Fraud
The government’s abject failure to prevent COVID fraud shows the risks of hasty and reckless spending.
The Human Cost of Pharmaceutical Price Controls is Too High
Price controls will result in the loss of life due to a lack of future research and development.
Price Controls Are Still Bad Medicine
Price controls on pharmaceuticals distort the medical marketplace and will not lower drug prices.
The Senate Must Reject Price Controls on Pharmaceuticals
Senators should reject price controls on pharmaceuticals; they will not lower prices and lead to fewer future cures.
The Senate Should Not Implement Price Controls on Pharmaceuticals
Price controls on pharmaceuticals will not lower prices and will lead to fewer future cures.
Limiting Access to Tobacco Harm Reduction Products Harms Public Health
The FDA’s decision to stop Juul from selling e-cigarette products in the U.S. will harm public health.
Regulating PBMs Will Not Lower Drug Costs
Increasing regulations on pharmacy benefit managers will not reduce the cost of pharmaceuticals.
Vaping Saves Lives
Tobacco harm reduction products like e-cigarettes are effective tools that help adults successfully quit smoking.